Narcotics Analgesics Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Chronic Pain
![]() |
Narcotics Analgesics Market |
The
narcotics analgesics market comprise of opioid and non-opioid pain relievers
that provide relief from moderate to severe pain. Opioid analgesics such as
morphine, codeine, oxycodone and fentanyl are commonly prescribed for cancer
pain, post-surgical pain and chronic severe pain. Increasing incidence of
chronic pain conditions like arthritis, back pain and cancer has resulted in
high demand for potent pain relievers.
The Global
narcotics analgesics Market Demand is estimated to be valued at US$
36.45 billion in 2024 and is expected to exhibit a CAGR of 12% over the
forecast period 2024 to 2031.
Key Takeaways
Key players operating in the narcotics analgesics market include Kimberly-Clark
Corporation, Essity AB, Georgia-Pacific LLC, Asia Pulp and Paper Group, Procter
& Gamble Co., Sofidel Group, CMPC Tissue S.A., WEPA Hygieneprodukte GmbH,
Metsä Group, Cascades Inc. These companies dominate the market with their
extensive product portfolio and global distribution network.
The market offers several growth opportunities such as new product launches,
expanding into emerging markets and strategic collaborations &
acquisitions. Major players are focusing on developing tamper-resistant and
abuse deterrent formulations of opioid analgesics to prevent non-medical use of
these drugs.
Globally, the narcotics analgesics market is expanding into Latin America, Asia
Pacific and Middle East regions owing to increasing healthcare expenditures,
rising standards of living and growing medical needs in these areas. However,
stringent regulations around opioid use in developed markets act as a challenge
for players eyeing global expansion opportunities.
Market Drivers
Growing geriatric population susceptible to chronic pain conditions like
osteoarthritis and lower back pain is a key factor driving the narcotics
analgesics market. According to WHO, 1.5 billion people suffer from chronic
pain globally and 20%-30% of the general population is affected by chronic pain
disorders.
Increasing availability of abuse-deterrent formulations of opioid drugs through
initiatives by leading players is also fueling the market growth. For instance,
Introduction of tamper-resistant formulations have reduced the risk of misuse
of these potent analgesics through alternate non-oral routes.
Market Restrain
Stringent regulations imposed by authorities like FDA on distribution and use
of opioid drugs hamper the market growth. Over-prescription of opioid drugs has
led to increasing addiction rates and fatalities. Governments are focusing on
mitigating opioid abuse crisis which acts as a key restrain for the global
narcotics analgesics market.
Preference for alternative pain management options like physical therapy,
acupuncture and chiropractic treatment also challenges the market growth to
some extent. Non-pharmacological treatments are increasingly adopted to avoid
side effects and dependency caused by long term use of opioids.
Segment Analysis
The narcotics analgesics market is dominated by opioids sub-segment led by
growing demand for potent pain relievers. Opioids such as morphine are highly
effective in relieving moderate to severe pain and have high Bioavailability
making them first choice for conditions like cancer pain. Non-opioids
sub-segment comprising acetaminophen and nonsteroidal anti-inflammatory drugs
is another major segment driven by increasing usage to treat mild to moderate
pain without risk of addiction.
Global Analysis
North America is the fastest growing region in the narcotics analgesics market
led by an aging population and rising prevalence of chronic diseases in the US
and Canada driving demand for strong pain management therapies. However, the
abuse and overuse of prescription opioids have led regulatory authorities to
tighten controls, restraining market growth. Europe represents second largest
regional market owing to high accessibility of healthcare and well-established
reimbursement policies helping patients afford expensive treatments involving
narcotic pain relievers. Asia Pacific is projected to witness highest CAGR
during the forecast period due to improving access to healthcare facilities,
increasing affordability as well as rising awareness about management of
chronic pain.
Get more insights on this topic: Narcotics
Analgesics Market
Comments
Post a Comment